Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.5.0.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-based Compensation, Activity
The following table summarizes the stock-based compensation expense from stock option awards, restricted common stock awards, employee stock purchase programs and warrants granted by Fortress for the three and six months ended June 30, 2016 and 2015:
 
 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
($ in thousands)
 
2016
 
2015
 
2016
 
2015
 
Employee awards
 
$
1,969
 
$
1,525
 
$
3,553
 
$
2,988
 
Non-employee awards
 
 
3
 
 
7
 
 
6
 
 
14
 
Fortress Companies (1)
 
 
1,051
 
 
393
 
 
2,330
 
 
393
 
Total stock-based compensation expense
 
$
3,023
 
$
1,925
 
$
5,889
 
$
3,395
 
 
(1)
Consists of approximately $9,000 of Avenue's compensation expenses, approximately $0.8 million of Checkpoint's compensation expense, approximately $147,000 of JMC's compensation expenses and approximately $93,000 of Helocyte's compensation expenses on stock grants for the three months ended June 30, 2016, and approximately $18,000 of Avenue's compensation expenses, approximately $1.9 million of Checkpoint's compensation expense, approximately $328,000 of JMC's compensation expenses and approximately $93,000 of Helocyte's compensation expenses on stock grants for the six months ended June 30, 2016. For the three and six months ended June 30, 2015, expense consists of $22,900 for Avenue, $0.1 million for Mustang, $0.2 million for Coronado SO and $44,700 for Checkpoint.
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes Fortress stock option activities excluding activity related to Fortress Companies:
 
 
 
Number of shares
 
Weighted average
exercise price
 
Total weighted
average intrinsic
value
 
Weighted average
remaining
contractual life
(years)
 
Options vested and expected to vest at December 31, 2015
 
 
1,779,365
 
$
4.37
 
$
666,396
 
 
6.32
 
Granted
 
 
-
 
 
-
 
 
-
 
 
-
 
Forfeited
 
 
(25,000)
 
 
2.10
 
 
-
 
 
-
 
Options vested and expected to vest at June 30, 2016
 
 
1,754,365
 
$
4.41
 
$
597,262
 
 
5.80
 
Options vested and exercisable
 
 
1,065,501
 
$
3.77
 
$
573,662
 
 
5.34
 
 
Nonvested Restricted Stock Shares Activity
The following table summarizes Fortress’ restricted stock and restricted stock unit award activity, excluding activity related to Fortress Companies (which is discussed below):
 
 
 
Number of shares
 
Weighted average 
grant price
 
Unvested balance at December 31, 2015
 
 
8,757,935
 
$
2.47
 
Restricted stock granted
 
 
1,240,868
 
 
2.77
 
Restricted stock cancelled
 
 
(33,333)
 
 
2.69
 
Restricted stock vested
 
 
(173,333)
 
 
2.73
 
Restricted stock units granted
 
 
405,000
 
 
2.90
 
Restricted stock units cancelled
 
 
(101,000)
 
 
3.64
 
Restricted stock units vested
 
 
(16,917)
 
 
3.55
 
Unvested balance at June 30, 2016
 
 
10,079,220
 
$
2.50
 
Schedule of Warrant Activities
The following table summarizes Fortress warrant activities, excluding activities related to Fortress Companies:
 
 
 
Number of shares
 
Weighted average
exercise price
 
Total weighted
average intrinsic 
value
 
Weighted average
remaining 
contractual life 
(years)
 
Outstanding as of December 31, 2015
 
 
569,835
 
$
6.31
 
$
120,700
 
 
1.84
 
Granted
 
 
100,000
 
 
3.00
 
 
-
 
 
4.92
 
Expired
 
 
(129,767)
 
 
5.59
 
 
-
 
 
 
 
Exercised (*)
 
 
(25,000)
 
 
1.37
 
 
33,000
 
 
 
 
Outstanding as of June 30, 2016
 
 
515,068
 
$
6.09
 
$
79,200
 
 
2.48
 
Exercisable as of June 30, 2016
 
 
415,068
 
$
6.83
 
$
79,200
 
 
1.89
 
(*) - cashless
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of options granted in 2016 was estimated using the following assumptions:
 
 
 
For the six
months ended
June 30,
2016
 
Risk-free interest rate
 
 
1.46% - 1.82
%
Expected dividend yield
 
 
-
 
Expected term in years
 
 
5.23-6.95
 
Expected volatility
 
 
96.89% - 102.05
%